Julian Michelotto1, Joseph M G V Gassner1, Simon Moosburner1, Vanessa Muth1, Madhukar S Patel2, Markus Selzner2, Johann Pratschke1, Igor M Sauer1, Nathanael Raschzok3,4. 1. Charité - Universitätsmedizin Berlin, Department of Surgery, Experimental Surgery, corporate member of Freie Universität Berlin, Humboldt- Universität zu Berlin and Berlin Institute of Health, Campus Charité Mitte | Campus Virchow-Klinikum, Berlin, Germany. 2. Department of Surgery, Abdominal Transplant and HPB Surgery, Ajmera Family Transplant Centre, Toronto General Hospital, Toronto, ON, Canada. 3. Charité - Universitätsmedizin Berlin, Department of Surgery, Experimental Surgery, corporate member of Freie Universität Berlin, Humboldt- Universität zu Berlin and Berlin Institute of Health, Campus Charité Mitte | Campus Virchow-Klinikum, Berlin, Germany. nathanael.raschzok@charite.de. 4. Department of Surgery, Abdominal Transplant and HPB Surgery, Ajmera Family Transplant Centre, Toronto General Hospital, Toronto, ON, Canada. nathanael.raschzok@charite.de.
Abstract
BACKGROUND: Liver transplantation is the only curative treatment option for end-stage liver disease; however, its use remains limited due to a shortage of suitable organs. In recent years, ex vivo liver machine perfusion has been introduced to liver transplantation, as a means to expand the donor organ pool. PURPOSE: To present a systematic review of prospective clinical studies on ex vivo liver machine perfusion, in order to assess current applications and highlight future directions. METHODS: A systematic literature search of both PubMed and ISI web of science databases as well as the ClinicalTrials.gov registry was performed. RESULTS: Twenty-one articles on prospective clinical trials on ex vivo liver machine perfusion were identified. Out of these, eight reported on hypothermic, eleven on normothermic, and two on sequential perfusion. These trials have demonstrated the safety and feasibility of ex vivo liver machine perfusion in both standard and expanded criteria donors. Currently, there are twelve studies enrolled in the clinicaltrials.gov registry, and these focus on use of ex vivo perfusion in extended criteria donors and declined organs. CONCLUSION: Ex vivo liver machine perfusion seems to be a suitable strategy to expand the donor pool for liver transplantation and holds promise as a platform for reconditioning diseased organs.
BACKGROUND: Liver transplantation is the only curative treatment option for end-stage liver disease; however, its use remains limited due to a shortage of suitable organs. In recent years, ex vivo liver machine perfusion has been introduced to liver transplantation, as a means to expand the donor organ pool. PURPOSE: To present a systematic review of prospective clinical studies on ex vivo liver machine perfusion, in order to assess current applications and highlight future directions. METHODS: A systematic literature search of both PubMed and ISI web of science databases as well as the ClinicalTrials.gov registry was performed. RESULTS: Twenty-one articles on prospective clinical trials on ex vivo liver machine perfusion were identified. Out of these, eight reported on hypothermic, eleven on normothermic, and two on sequential perfusion. These trials have demonstrated the safety and feasibility of ex vivo liver machine perfusion in both standard and expanded criteria donors. Currently, there are twelve studies enrolled in the clinicaltrials.gov registry, and these focus on use of ex vivo perfusion in extended criteria donors and declined organs. CONCLUSION: Ex vivo liver machine perfusion seems to be a suitable strategy to expand the donor pool for liver transplantation and holds promise as a platform for reconditioning diseased organs.
Entities:
Keywords:
Clinical application; Liver transplantation; Machine perfusion; Systematic literature review
Authors: A Joseph Tector; Richard S Mangus; Paul Chestovich; Rodrigo Vianna; Jonathan A Fridell; Martin L Milgrom; Carrie Sanders; Paul Y Kwo Journal: Ann Surg Date: 2006-09 Impact factor: 12.969
Authors: Tadahiro Uemura; Lucas E Nikkel; Christopher S Hollenbeak; Varun Ramprasad; Eric Schaefer; Zakiyah Kadry Journal: Transpl Int Date: 2012-04-06 Impact factor: 3.782
Authors: Carlo D L Ceresa; David Nasralla; Christopher J E Watson; Andrew J Butler; Constantin C Coussios; Keziah Crick; Leanne Hodson; Charles Imber; Wayel Jassem; Simon R Knight; Hynek Mergental; Rutger J Ploeg; Joerg M Pollok; Alberto Quaglia; A M James Shapiro; Annemarie Weissenbacher; Peter J Friend Journal: Liver Transpl Date: 2019-07-18 Impact factor: 5.799
Authors: Xavier Muller; Andrea Schlegel; Philipp Kron; Dilmurodjon Eshmuminov; Michael Würdinger; David Meierhofer; Pierre-Alain Clavien; Philipp Dutkowski Journal: Ann Surg Date: 2019-11 Impact factor: 12.969
Authors: Michael E Sutton; Sanna op den Dries; Negin Karimian; Pepijn D Weeder; Marieke T de Boer; Janneke Wiersema-Buist; Annette S H Gouw; Henri G D Leuvenink; Ton Lisman; Robert J Porte Journal: PLoS One Date: 2014-11-04 Impact factor: 3.240
Authors: Hynek Mergental; Barnaby T F Stephenson; Richard W Laing; Amanda J Kirkham; Desley A H Neil; Lorraine L Wallace; Yuri L Boteon; Jeannette Widmer; Ricky H Bhogal; M Thamara P R Perera; Amanda Smith; Gary M Reynolds; Christina Yap; Stefan G Hübscher; Darius F Mirza; Simon C Afford Journal: Liver Transpl Date: 2018-10 Impact factor: 5.799